Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
06/26/2024
The German Biobank Node (GBN), BBMRI.at and the Swiss Biobanking Platform (SBP) have jointly launched a film aimed at researchers.
06/11/2024
GBN and patient organisations call for greater use of academic biobanks and intensified patient participation in biomedical research.
06/10/2024
In the second part of the anniversary video series, members of the Steering Committee have their say on the topic of "Highlights of a decade".
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2024 All rights reserved.